Brain Health & DementiaCompany report · early trial
Sam Altman-backed firm tests stronger doses of a pill aimed at dementia
Retro Biosciences is adding 32 healthy volunteers to its first safety test of a pill meant to help brain cells clear out waste, after early doses caused no major side effects.
